Nabsys Electronic Genome Mapping Advances Cancer Analysis
Providence, Rhode Island, USA, September 17, 2026 Nabsys, Inc. has announced the publication of research from Augusta University demonstrating...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Providence, Rhode Island, USA, September 17, 2026 Nabsys, Inc. has announced the publication of research from Augusta University demonstrating...
PROVIDENCE, R.I., July 31, 2026 Nabsys 2.0, LLC has entered into a multi-year research collaboration with Indiana University School...
PLYMOUTH MEETING, Pa., June 12, 2026 Braeburn has announced the presentation of new clinical and real-world research findings for...
SAN DIEGO, June 19, 2026 Fapon Biopharma and MOTE Therapeutics have announced plans to present their innovative dual-targeting, dual-platform...
BOSTON and ROLLE, Switzerland, June 19, 2026 SOPHiA GENETICS, a global leader in AI-driven precision medicine, has announced the...
